BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 1, 2016
View Archived Issues
L-Citrulline safe but has rapid clearance in patients with sickle cell disease
Read More
Atlanthera patents anticancer agents
Read More
Chinese scientists disclose cytidine dimers for the treatment of cancer
Read More
University College Cardiff Consultants develops AR antagonists
Read More
Esteve announces dual sigma1 and mu-opioid receptor ligands
Read More
Boehringer Ingelheim and Inventiva announce research and drug discovery collaboration
Read More
Bristol-Myers Squibb presents HIV maturation inhibitors
Read More
BioMarin withdraws Kyndrisa MAA, discontinues development of follow-on products
Read More
Nuplazid now available for prescription in the U.S.
Read More
Studies with CM-4620 in pancreatitis models suggest CRAC inhibition is beneficial
Read More
Soligenix's SGX-943 gets FDA fast track designation
Read More
FDA grants emergency use authorization to Idylla Ebola Virus Triage Test
Read More
Amicus's migalastat hydrochloride obtains first approval in Europe
Read More
Teva receives complete response letter for SD-809 for the treatment of chorea associated with HD
Read More
Contravir Pharmaceuticals to buy Ciclofilin Pharmaceuticals
Read More
FDA approves Teflaro in pediatric patients
Read More
Chugai licenses SA-237 rights to Roche
Read More
Imbruvica approved in E.U. as first-line treatment for CLL
Read More
FDA accepts for review sNDA for Vertex's Orkambi
Read More
Phase III study of patritumab in NSCLC not to continue
Read More
ASCL1 may be useful as a biomarker for lung adenocarcinoma in smokers
Read More
EMA committee supports expanding approval of Tysabri
Read More
Trevicta 3-monthly injection approved for schizophrenia in E.U.
Read More
Phase II study of CymaBay's MBX-8025 shows proof of concept
Read More
FDA accepts for filing Radius Health's NDA for abaloparatide-SC
Read More
Lexicon's NDA for telotristat accepted for filing by FDA
Read More
Brentuximab vedotin receives FDA orphan designation for adult T-cell leukemia/lymphoma
Read More
